Amesite (AMST) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
6 Feb, 2026Product and market overview
Develops and markets AI-driven solutions for B2C and B2B, focusing on healthcare and professional learning.
NurseMagic app provides real-time support for healthcare professionals, reducing charting time and improving communication.
First in market with an AI-powered professional learning platform, generating $2.4M in revenue since launch.
Microsoft partnership enables a turnkey AI-supported training platform for higher education.
NurseMagic adopted by users in all 50 states and 21 countries within six months of launch.
Sales, revenue growth, and market traction
Over 10,000 free B2C users enrolled within six months; B2C subscriptions launched December 2024.
B2B revenue established in home care markets, with enterprise pilots involving companies with 30,000 employees across 41 states.
Targeted franchise locations exceed 700, with $5.2B annual revenue of targeted customers.
Achieves profitability with fewer than 30,000 B2C users and 17,000 B2B users.
B2C and B2B feedback is highly positive, with attractive price points and rapid sales cycles.
Technology, security, and continuous improvement
Infrastructure integrates real-world and synthetic data, with PHI scrubbed for AI scale.
Meets HIPAA requirements, with 24/7 automated threat monitoring and strict access controls.
Over 20 proprietary models, 1B+ lines of training data projected in year one, and 5 feature upgrades per week.
More than 100 APIs integrated, including government databases and payment gateways.
Continuous model refinement ensures integration with existing workflows and top performance.
Latest events from Amesite
- Auditors flagged going concern risks; offering led by Laidlaw & Company (UK) Ltd.AMST
Registration filing26 May 2026 - Revenue increased and net loss narrowed, but going concern risks persist despite new capital.AMST
Q3 202618 May 2026 - AI healthcare firm offers 4.8M shares for resale, with viability dependent on warrant exercise proceeds.AMST
Registration filing12 May 2026 - Healthcare AI firm offers shares and warrants to fund growth amid ongoing losses and compliance risks.AMST
Registration filing20 Apr 2026 - NurseMagic™ app drives rapid revenue growth and market adoption in healthcare AI.AMST
Investor presentation6 Feb 2026 - Revenue surged but losses persist; going concern and Nasdaq compliance risks remain.AMST
Q2 20266 Feb 2026 - Director and auditor approved; NurseMagic gains traction; strong insider investment.AMST
AGM 202510 Jan 2026 - NurseMagic's rapid adoption and scalable sales model position the company for profitable growth in 2025.AMST
Sidoti Micro-Cap Virtual Conference9 Jan 2026 - Flexible $100M shelf registration targets growth in AI-driven education and healthcare solutions.AMST
Registration Filing16 Dec 2025